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The epithelial lining of the mammalian intestinal mucosa is an
excellent tissue for studying molecular aspects of development,
differentiation and tumorigenesis. Morphogenesis from fetal endo-
derm to the adult structure occurs along strict temporal and spatial
gradients during the last 5 days of rodent gestation (Trier and
Moxey, 1979; Deren, 1987). The adult intestinal mucosa is
organized as a single-layered epithelium lining crypts, which
invaginate below the surface of the gut and villi, which protrude
into the gut lumen. Cells lining the villi are continually being
replaced by the proliferation, differentiation and migration of stem
cells within the crypts (Potten and Loeffler, 1990). Thus, the crypt
and villus structures represent undifferentiated and differentiated
cellular compartments respectively. The expression patterns of
numerous genes have demonstrated that differential gene expres-
sion occurs in two dimensions – along the crypt–villus axis and
along the proximal–distal axis (Asp et al, 1975; Traber, 1990;
Trezise and Buchwald, 1991). Thus, geographic and cell-specific
patterns of gene expression are established during a period of rapid
cellular proliferation, differentiation and morphogenesis, and
maintained despite continual cell migration and renewal.
The transcriptional regulation of an increasing number of
intestinal genes have been described and from this work intestine-
specific promoter elements and transcription factors are beginning
to emerge (Cohn et al, 1992; Suh et al, 1994; Traber, 1994).
Molecular research in the intestine has so far focused on transcrip-
tional regulation in mature, fully differentiated intestinal cell
types. To our knowledge no promoter elements have been identi-
fied which function in developing or undifferentiated intestinal
epithelial cells. To date, the regulation of only three genes which
are expressed in undifferentiated intestine have been reported: the
murine homeobox gene cdx-1 (Hu et al, 1993), the cystic fibrosis
transmembrane conductance regulator (CFTR) (Koh et al, 1993;
McDonald et al, 1995) and the fetal serum protein a-fetoprotein
(AFP) (Tyner et al, 1990; Cirillo et al, 1995). In each of these
cases, analysis was either performed in colonic carcinoma cell
lines or focused on elements which repress expression in mature
enterocytes. Since transcripts which function in development,
lineage determination and tumorigenesis might be expected to first
appear in crypt or fetal intestinal cells, promoter elements which
regulate transcription in undifferentiated intestinal cells would be
of interest.
IEC cells are a series of spontaneously immortalized crypt-like
cell lines from fetal and newborn rat small intestine (Quaroni et al,
1979; Quaroni and Isselbacher, 1981; Quaroni, 1985). In the IEC-
18 cell line, expression of the multidrug resistance (MDR) gene,
mdr1a, has previously been observed (KL Duechars, unpublished
data). MDR genes encode P-glycoprotein, a transmembrane efflux
pump which mediates the multidrug resistant phenotype in a
variety of tumours (for reviews see Gottesman and Pastan, 1993;
Gottesman et al, 1995, 1996). Three classes of MDR genes have
been defined. Only classes I and II can confer drug resistance,
although their physiological substrates remain unidentified; class
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(Ruetz and Gros, 1994). Humans have only class I and III genes
(MDR1 and MDR3/MDR2), while rodents express all three
classes – mdr1a/mdr3, mdr1b/mdr1 and mdr2 in mouse; pgp1,
pgp2 and pgp3 in hamster; mdr1a/pgp1, mdr1b/pgp2 and
mdr2/pgp3 in rat. Each family member exhibits distinct patterns of
tissue-specific expression with the intestinal epithelium being one
of the few normal tissues known to express high levels of mdr1a
(Gatmaitan and Arias, 1993). Transcriptional regulation of
multiple family members, from many species, has been studied
extensively (Thorgeirsson et al, 1994; Smit et al, 1995). However,
very few cell type-specific promoter elements have been described
in MDR genes, the only published example being a hepatoma cell-
specific enhancer in the mouse mdr1b promoter (Song et al, 1995).
It is hypothesized that insight into gene regulation in undifferen-
tiated intestinal cells can be obtained through study of MDR gene
expression in IEC-18 cells as a model system. First, to identify
promoter elements functioning in primitive intestinal cell types,
the hamster pgp1 promoter was mapped in IEC-18 cells. Second,
employing a quantitative reverse transcription polymerase chain
reaction (RT-PCR) comparative analysis to validate the use of
IEC-18 cells as a model, novel gene-specific expression patterns
of MDR family members were identified in undifferentiated
intestinal cell types.
MATERIALS AND METHODS
Recombinant plasmids and oligonucleotides
Generation of pgp1 promoter and deletion constructs were
described in Zastawny and Ling (1993). Enhancer constructs
p100/25CAT and p25/100CAT were constructed by blunt-ended
cloning of an Xba1(–100)/Hpa1(–25) fragment from the pgp1
promoter into the Bgl II site of pCAT-Promoter (Promega) in the
forward and reverse orientations respectively. PCR primers for rat
ribosomal protein L32, 5¢ (AGAGGCATCGACAACAGGGTG)
and 3¢ (CTATTCATTCTCTTCGCTGCG), result in a 294-bp
product (Rajchel et al, 1988). MDR gene-specific primer pairs
were selected from the 3¢ untranslated regions of the three rat mdr
genes (Deuchars et al, 1992). Sequences for the primers used
were: mdr1a – 5¢ (CTGTGACCATGCGAGATG) and 3¢
(GGTGCTAGGGATCTGGAC), mdr1b – 5¢ (TATTTGAGGTGC-
TAAGTATTTC) and 3¢ (GTGCGGAAAGGCATCCCA), mdr2–5¢
(AACTTATGAACTTGTTACAGTA) and 3¢(CCAAATGTC-
CATGGAAG).
Cell culture, transient transfection and CAT assays
RC3 (rat hepatoma) cells were maintained in SWIM S77 medium
supplemented with 4 mM glutamine, 20% horse serum and 5%
fetal bovine serum (FBS). AuxB1 (Chinese ovary), NRK-52E (rat
kidney) and SW620 (human colon carcinoma) lines were carried
in a-MEM plus 10% FBS. IEC cells were grown in a-MEM
supplemented with 20 mM glucose, 2 mM glutamine, 0.27 units
ml–1 insulin and 5% FBS. Transient transfections of RC3, AuxB1
and SW620 were performed with lipofectAMINE reagent
(GibcoBRL) as directed by the manufacturer. IEC-18 cells (107
cells in 100 mL of HEPES-buffered saline) were electroporated in
0.4-cm gap cuvettes with one pulse at 450 V, 125 mFd (BioRad
Gene Pulser). In all cases pCMV–b-gal was co-transfected as an
internal control for transfection efficiency. CAT (phase-extraction
method) and b-gal assays were performed 48 h after transfection
(1993) and data were represented as the mean and standard error
of 3–4 independent trials where CAT activity was normalized to
b-gal.
RNA isolation
Small intestinal crypts, villi and colonic intestinal crypts were
isolated from 8-week-old male CD rats by incubation in 30 mM
EDTA at 37°C and mechanical vibration of everted intestinal
segments following previously established methods (Cano-Gauci
et al, 1993) with the following modifications:
1. All tissue samples were isolated in calcium- and magnesium-
free phosphate-buffered saline without fixation.
2. Villi, each containing approximately 3500 cells, were released
within the first 5 min of incubation in EDTA and confirmed to
be free of crypts under light microscopy.
3. Mixed villus and crypt populations released over the next 20
min by multiple rounds of vibration into fresh solutions were
discarded.
4. Single crypts, containing roughly 250 cells each, released after
30 min of EDTA incubation were examined under light
microscopy, and individually selected under suction with
drawn-out, bent pasteur pipettes.
Pooled populations of crypts and villi were isolated from the
duodenum, jejunum, ileum and colon. RNA was prepared from all
samples immediately after isolation with 1 ml of TRIZOL reagent
(GibcoBRL), according to manufacturer’s specification. RNA
from cultured cell lines and whole tissue was isolated directly with
the TRIZOL reagent. Fetal intestinal RNA at various stages of
development was prepared from whole intestine of CD rat
embryos, pulverized in liquid nitrogen with a mortar and pestle,
using the acid-guanidinium thiocyanate method of Chomczynski
and Sacchi (1987).
Northern blot analysis
For Northern blot analysis, 5 mg of RNA were separated by elec-
trophoresis on 0.75% agarose-formaldehyde gels in phosphate
buffer and transferred to Zetaprobe membranes (Bio-Rad Labs) in
10 ´ saline–sodium citrate (SSC). Filters were prehydridized at
42°C in 45% formamide, 5 ´ Denhardt’s, 2% sodium dodecyl
sulphate (SDS), 5 ´ Saline–Sodium phosphate–EDTA (SSPE) and
100 mg ml–1 each of salmon sperm DNA and poly-A+.
Hybridization was performed under the same conditions using
random-primed,  32P-labelled cDNA probes for mouse L32 (Dudov
and Perry, 1984) or the 2B13-155 probe which recognizes rat
MDR genes (generously provided by JA Silverman). Filters were
washed in 2 ´ SSC, 0.2% SDS for 30 min at 42°C, followed
by 30 min wash in 1 ´ SSC and 0.1% SDS at 65°C before
exposure to a phosphorimager screen and quantification with
ImageQuant software (Molecular Dynamics).
RT-PCR analysis
Reverse transcription was performed with 1 mg of DNAase-treated
RNA for 1 h at 37°C with 25 pmol of a dT24 synthetic oligo-
nucleotide, 12 units AMV reverse transcriptase (Boehringer
Mannheim) in the supplied incubation buffer, 36 units RNAGuard
(Pharmacia) and 1 mM each of dATP, dGTP, dCTP and dTTP
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amplified in 10 mM Tris pH 8.3, 1.5 mM magnesium chloride,
50 mM potassium chloride, 0.1% Triton X-100, 0.2 mM each of
dNTPs, 25 pmol each of 5¢ and 3¢ primers and 2 units of Taq poly-
merase (Perkin-Elmer Cetus) with a final reaction volume of
50 mL, overlaid with an equal volume of mineral oil.
Amplification was performed for 30 sequential cycles at 95°C for
30 s, 55°C for 30 s, 72°C for 30 s, followed by a final 10-min
extension at 72°C. Equal aliquots of each PCR reaction were sepa-
rated on a 2% agarose gel and photographed following ethidium
bromide staining.
Quantitative RT-PCR
Quantitative RT-PCR was performed as described in Murphy et al
(1990). Wherever possible, reaction mixes were used to increase
consistency. Following reverse transcription as described above,
serial 1:2 dilutions of cDNA were made starting with the amount
of cDNA empirically determined to permit amplification within
the linear range of the gene of interest. Thus, serial dilutions were
initiated with the following amounts of cDNA, expressed as ng
of RNA in the cDNA reaction: for mdr1a – 10 ng from small
intestinal crypts and villi, 50 ng from colonic crypts, 100 ng from
fetal intestine and IEC-18 cells; for mdr1b – 100 ng from small
intestinal crypts, fetal intestine and IEC-18 cells; for L32 – 100 pg
from colonic crypts, fetal intestine and IEC-18 cells, 1 ng from
small intestinal villi and crypts. Dilutions were amplified as
described above except for the inclusion of 2 mCi (32P)dCTP in
each reaction. For each sample, eight serial 1:2 dilutions were
amplified and 20 ml of PCR product were run on 5% acrylamide
gels which were subsequently dried and exposed to a phosphor-
imager screen for 16 h. Quantification of gel bands was performed
with ImageQuant software (Molecular Dynamics). For each
sample, amplification of mdr1a, mdr1b and L32 was performed at
the same time, independently amplified from the same cDNA
reaction, using the same amount of specific radioactivity and
exposed to the phosphorimager screen together. To determine the
relative amounts of a gene expressed between two samples, the
phosphorimaging counts are compared at the same amount of
input cDNA, within the exponential range of each gene. MDR
counts are normalized against similarly analysed L32 levels,
corrected for tissue abundance.
RESULTS
Deletion mapping of the pgp1 promoter in IEC-18 cells
In humans, only the MDR class I transcript has been associated
with expression in the intestinal epithelium and multidrug
resistance in tumours. As a candidate gene in which to identify
intestine-specific promoter elements, a series of previously charac-
terized hamster MDR class I promoter deletion constructs
(Zastawny and Ling, 1993) were studied in IEC-18 cells. Although
IEC-18 is a rat cell line, the hamster MDR promoter was employed
in this study because the rat mdr1a promoter has not yet been
cloned. MDR promoters are highly conserved across rodent
species among classes (Zastawny and Ling, 1993), the rat mdr1b
promoter (Silverman and Hill, 1995) having 73% homology to
hamster pgp2 and only 47% similarity to hamster pgp1. Although
the cross-species promoter analysis used in this study may limit
the applicability of the findings to MDR gene regulation, any
identified regulatory regions will still reflect promoter elements
which function in intestinal gene expression.
Deletion constructs of the hamster pgp1 promoter region from
–3000 to –10 bp (relative to the transcription start site) driving
a CAT reporter gene, were transiently transfected into IEC-18
(Figure 1). CAT activity, normalized to co-transfected CMV–b-
gal, is expressed relative to the largest construct, pEco1. Deletion
from –3000 to –299 has no significant effect on promoter activity.
A 13-fold increase in CAT activity is seen between pNsi1 and
pBgl1, suggesting the deletion of a repressor element between
–299 and –254. Further deletion from –100 to –52 results in a
12-fold drop in reporter activity, indicating the presence of an
enhancer region. Core promoter activity is maintained up to –25,
with further deletion significantly reducing the reporter expres-
sion. Previously published data demonstrate the repressor and
enhancer regions identified here, do not exhibit the same activity
in AuxB1 (Zastawny and Ling, 1993), and those findings were
reproduced in the present study (data not shown). Similarly, intron
1 sequences which were shown to have enhancer activity in
AuxB1 (plasmids int-6 and int-8), do not function in IEC-18
(Figure 1).
To further define and demonstrate the tissue-specificity of the
potential repressor and enhancer elements, these regions were
subcloned upstream of a heterologous promoter. Two repressor
constructs were made by subcloning the regions between –299 to
–254 and from –391 to –254, in both orientations, in front of the
enhancerless SV40 promoter in the pCATpromoter vector. These
constructs failed to demonstrate repressor activity in the forward
orientation and while the reverse orientation abolished reporter
activity, this effect was shown not to be cell type-specific (data not
shown).
The potential enhancer region of the pgp1 promoter from –100
to –25 was subcloned into pCATpromoter in the forward (p100/25
CAT) and reverse (p25/100 CAT) orientations. In SW620, RC3
Multidrug resistance genes in the intestinal epithelium 1125
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Figure 1 Activity of pgp1 promoter-CAT deletion constructs in IEC-18.
Deletion constructs of the hamster pgp1 promoter region driving a CAT
reporter gene were transiently transfected into IEC-18 along with a CMV–b-
gal plasmid by electroporation. CAT activity, normalized to b-galactosidase
levels, are expressed relative to the largest construct, pEco1. The constructs
int-6 and int-8 are identical to pEco1 with the addition of intron 1 seqences in
the forward and reverse orientations respectivelyand AuxB1 cells these constructs have the same activity as
pCATpromoter (Figure 2). In contrast, transfection of these
constructs into IEC-18 resulted in an increase in reporter activity
over that of pCATpromoter. Thus, the –100 to –25 region of the
pgp1 promoter contains an enhancer activity which functions in
an orientation- and promoter context-independent manner, specifi-
cally in IEC-18 cells.
Quantitative RT-PCR of MDR expression in the intestine
Surprisingly, transcript analysis in IEC-18 cells revealed a greater
expression of mdr1b than mdr1a. Figure 3A depicts a Northern
blot of IEC-18 RNA probed with 2B13-155, an mdr1b cDNA frag-
ment which recognizes all three classes of MDR genes (Silverman
et al, 1991). The 5.2- and 4.4-kb bands have previously been
shown to correspond to mdr1a and mdr1b, respectively (Schrenk
et al, 1992), and these transcript species were confirmed by
probing with gene-specific oligonucleotides derived from the
divergent 3¢UTRs of each rat gene (Deuchars et al, 1992) (data not
shown). In order to more fully explore the nature of MDR gene
expression in IEC-18 cells, a quantitative RT/PCR assay was
established to compare MDR gene-specific expression between
intestinal tissue taken from fetal intestine, and along the prox-
imal–distal and crypt–villus intestinal axes.
Initially, RT-PCR analysis was performed in various cell lines
and intestinal tissues by amplification of mdr1a, mdr1b and mdr2
using equal amounts of a single cDNA synthesis reaction (Figure
3B). Contamination of RNA samples with genomic DNA was
ruled out by amplification of RNA without reverse transcription
and gene-specificity of the PCR primers was demonstrated by
amplification of MDR genes against each MDR genomic DNA
template (Deuchars et al, 1992) (not shown). The observed sizes of
the major PCR product for mdr1a, mdr1b and mdr2 are consistent
with their expected 555 bp, 507 bp and 650 bp respectively. In
some cases, unexpected PCR products were seen. In the quantita-
tive RT-PCR trials described below, these various bands were
observed inconsistently and were always less intense than the
predicted product. Some of these bands were also observed in the
negative control NRK-52E cells and were considered non-specific
PCR products; others likely represent alternative-splicing in the
3¢-untranslated region of MDR genes. Differences in 3¢-untrans-
lated region processing have been reported for MDR genes
(Endicott et al, 1987; Van der Bliek et al, 1987) and are of
unknown biological significance. In this study, only the predicted
PCR product size, which is usually the dominant product, was
considered.
In Figure 3B, the greater steady-state expression of mdr1b than
mdr1a in IEC-18 cells is reflected in the RT-PCR assay. Mdr2
expression cannot be detected in IEC-18 cells. The relatively
quantitative nature of the RT-PCR is further evidenced by MDR
amplification of rat liver RNA, where the high levels of mdr1a and
mdr2 relative to mdr1b observed is consistent with the previously
documented pattern seen in liver (Brown et al, 1993; Lee et al,
1993). In contrast to the MDR expression profile of IEC-18 cells,
whole tissue RNA preparations from adult rat small intestine and
colon express high levels of mdr1a, low levels of mdr1b and still
lower amounts of mdr2. The general patterns do not appear to vary
across the duodenum, jejunum and ileum. Intermediate patterns of
MDR expression are seen in fetal rat intestine. At day 17 of gesta-
tion, mdr1a and mdr1b are expressed in approximately equal
amounts. By day 20, the adult pattern of MDR expression is begin-
ning to emerge.
A quantitative RT-PCR assay was used to obtain numerical data
on the relative expression of mdr1a and mdr1b across the prox-
imal–distal and crypt–villus axes of adult intestine, and to deter-
mine whether the patterns of MDR expression seen in IEC-18
cells reflect those seen in undifferentiated crypt/fetal intestinal
cells. Commonly used normalizing genes such as tubulin, actin,
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Figure 2 Tissue-specificity of the pgp1 enhancer region. The –100 to –25
region of the pgp1 promoter was cloned upstream of the SV-40 promoter in
the pCAT promoter vector in both forward and reverse orientations (p100/25
CAT and p25/100 CAT, respectively). Activity of these constructs was
analysed in various MDR expressing cell lines, normalized to CMV-bgal, and
expressed relative to the enhancer-less pCAT promoter
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Figure 3 RT/PCR detection of MDR gene expression. (A) Northern blot of
RNA from IEC-18 cells hybridized with the generic MDR probe, 2B13-155.
The mdr1a and mdr1b transcripts of 5.2 and 4.4 kb, respectively, were
determined relative to the mobilities of the 28S and 18S ribosomal bands.
(B) Ethidium bromide stained 2% agarose gels depicting products of MDR
gene-specific PCR reactions. A 100-bp DNA ladder is loaded as a size
marker. Gene-specific PCR amplifications from various cells and intestinal
tissues. Whole tissue was used for RNA isolation from fetal intestine, small
intestine, colon and liverglyceraldehyde-3-phosphate dehydrogenase and b2-microglobulin
were all expressed at vastly different levels in small intestinal
crypts and villi (not shown). Ribosomal L32 exhibited the least
variation among samples and was used as an internal RNA
standard to control for the actual amount of starting RNA, sample
degradation and efficiency of the cDNA reaction. For quantitative
RT-PCR, the amount of initiating cDNA which permits amplifica-
tion in the exponential range had to be empirically determined for
each gene in each cell type (see Materials and Methods). These
values reflect the different levels of specific transcript in the
various cells; for L32, the amounts of initiating cDNA required for
each of the cell types are consistent with their relative expression
of L32 as demonstrated by Northern blot analysis. Using ethidium
bromide staining of ribosomal RNA bands for normalization, the
relative expression levels of L32 were determined to be 7 times
less in villi, 4 times less in small intestinal crypts, and 2 times
more in fetal intestine as compared to IEC-18 cells and colonic
crypts (data not shown). These values were factored in when using
L32 as a normalizing standard.
Shown in Figure 4 are typical results from a quantitative RT-
PCR experiment comparing mdr1a expression in IEC-18 cells and
ileal villi. For all samples, mdr1a levels are compared at 3 ng of
input RNA, which is within the exponential range of amplification.
L32 levels were analysed at 30 pg and multiplied by 7 for
intestinal villi, multiplied by 4 for small intestinal crypts, and
divided by 2 for fetal intestine to correct for the average differen-
tial expression of L32. In Figure 4, the apparent 6.8-fold difference
in L32 levels between IEC-18 cells and ileal villi reflects the true
Multidrug resistance genes in the intestinal epithelium 1127
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Figure 4 Quantitative RT/PCR of mdr1a gene expression. Representative images and log–log plots of PCR products from eight serial 1:2 dilutions of IEC-18
and ileal villi cDNA. At the top are photographs of phosphorimager data set to linear ranges which optimize visualization of the bands. Amplifications of mdr1a
and L32 are shown with the highest dilution beginning on the left. For log–log plots, raw phosphorimaging data of the above images are depicted with symbols
and dashed lines, with the fitted linear regression superimposed in solid lines. Dotted vertical lines indicate the level of input RNA selected for comparison
between samplessevenfold difference in their steady-state expression of L32 as
demonstrated by Northern probing. Thus, normalization of mdr1a
densitometric units by corrected L32 densitometric units, (3.6 ´
106)/(2.3 ´ 105 ´ 7) = 2.24 and (3.3 ´ 104)/(1.5 ´ 106) = 0.022,
results in a difference in mdr1a expression of 2.24/0.022 = 102-
fold between ileal villi and IEC-18 cells. Mdr1b levels were
measured at the same time as mdr1a and L32, and analysed in an
identical fashion, with mdr1b densitometric units being compared
at 5 ng of input RNA across all samples.
Figure 5 summarizes the amounts of MDR expression in
various tissues relative to that of IEC-18 cells. As seen in Figure
5A, mdr1a expression in IEC-18 cells is similar to that in fetal
intestine, approximately 10 times less than small intestinal crypts
and 100 times less than villi. In contrast, mdr1b levels in IEC-18
cells are on the same order of magnitude as fetal intestine and
small intestinal crypts (Figure 5B). Levels of mdr1b transcript in
small intestinal villi and colonic crypts were below the limits of
reliable quantification in this assay. Along the crypt–villus axis
there is clearly a predominance of mdr1a in villi, while both mdr1a
and mdr1b are expressed in crypts. There do not appear to be large
differences in MDR gene expression along the intestinal prox-
imal–distal axis, although jejunal villi express slightly less mdr1a
and jejunal crypts more mdr1b. MDR expression in colonic crypts
parallels that of intestinal villi. From this analysis, it is apparent
that there is a progression from mixed mdr1a and mdr1b expres-
sion to predominantly mdr1a as cells mature from crypts to villi in
the small intestine. Although the mdr1b expression seen in fetal
intestine may include a contribution from other cell types, IEC-18
cells appear to reflect the MDR expression profile of fetal intestine
around day 17 of gestation.
MDR gene expression in the IEC series
To determine whether the MDR expression pattern observed in
IEC-18 cells could be generalized to other cells of the IEC series,
mdr1a and mdr1b expression was analysed in the other five IEC
cell lines – IEC-6, IEC-14, IEC-17, IEC-19 and IEC-20. As in
IEC-18, RT-PCR analysis shows that mdr1b is highly expressed in
these cell lines, in most cases in excess of mdr1a (Figure 6A). In a
single trial of quantitative RT-PCR with the same RNA, these
general patterns are confirmed, relative to the transcript levels in
IEC-18 (Figure 6B). IEC-14 appears to be an exception, appar-
ently expressing more mdr1a than mdr1b and in fact this cell line
is unique from the others in that it was originally isolated as an
epithelial clone growing out of a fibroblast culture (Quaroni et al,
1979). However, the magnitude of the differences in MDR gene
expression seen in Figure 6B are on the order of that seen between
IEC-18 and fetal or small intestinal crypt cells. Thus, the higher
expression of mdr1a seen in IEC-14 is on the same order of magni-
tude seen in small intestinal crypts, rather than villi.
DISCUSSION
MDR gene expression was characterized in IEC-18 cells in order
to explore gene regulation in the undifferentiated intestinal epithe-
lium. To identify promoter elements which may regulate gene
expression in primitive intestinal cells, the hamster class I
promoter was characterized in IEC-18 cells.
Deletion mapping of a previously established series of hamster
pgp1 promoter constructs identified a putative repressor region
between –299 and –254. Transcriptional repression in eukaryotes
can occur through a number of mechanisms which range from the
action of true silencers to interference with the action of transcrip-
tional activators (for reviews see Herschbach and Johnson, 1993;
Cowell, 1994). The inability of the repressor region to function on
a heterologous promoter in a position and orientation independent
manner indicates that this region does not contain a typical
silencer. The repressor region may require interaction with
elements in the pgp1 promoter not included in the present
constructs. If so, this region would bind a factor which inhibits the
1128 M Li et al
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(B) Quantitative RT-PCR of MDR genes in IEC cells. The graph summarizes
the expression of mdr1a and mdr1b in IEC cells, relative to IEC-18. Mdr1a
levels in IEC-19 and mdr1b in IEC-20 were not determined in this experimentfunction of a specific activator either by competing for DNA
binding or blocking activation. A search through the NCBI tran-
scription factor database failed to identify a match to any known
promoter elements. However, this region does contain a stretch –
GCAGAAGGCCAAGTGCA – which is identically conserved in
the murine class 1 promoter (Hsu et al, 1990). Further studies
demonstrating protein binding to this region and interaction with
neighbouring enhancer regions will be required.
A region fulfilling the minimal requirements for an enhancer
was identified between –100 and –52. This region was shown to
enhance transcription in both forward and reverse orientations,
from a heterologous promoter, specifically in IEC-18 cells. The
lack of activity in SW620 (human colon carcinoma), RC3 (rat
hepatoma) and AuxB1 (hamster ovary) indicates that this enhancer
functions preferentially in primitive small intestinal epithelial
cells. Located within this region is an enhancer activity and
consensus NF-IL6 binding site which is conserved between
murine mdr1a and mdr1b, human mdr1, and hamster pgp1
promoters (Yu et al, 1993; Combates et al, 1994) (Figure 7). In
addition, an overlapping 14 nucleotide stretch – CAACCT-
GTTTCGCA – is identically conserved between class I promoters
from human, mouse and hamster (Hsu et al, 1990; Madden et al,
1993; Zastawny and Ling, 1993) (Figure 7). Deletion of this 14-bp
element from the murine mdr1a promoter was shown to decrease
reporter gene expression in NIH 3T3 fibroblasts and a DNAase I
footprint was demonstrated in macrophage-like cell lines (Cohen
et al, 1994). It remains to be determined whether the region
exhibiting enhancer activity in IEC-18 cells corresponds to these
same elements, however the enhancer identified here does appear
to demonstrate specificity for undifferentiated intestinal cells.
MDR gene expression in the intestinal epithelium has been
reported by numerous investigators in human (Fojo et al, 1987;
Thiebaut et al, 1987), mouse (Croop et al, 1989; Buschman et al,
1992), hamster (Mukhopadhyay et al, 1988; Bradley et al, 1990)
and rat (Trezise and Buchwald, 1991). These studies have all iden-
tified the class I gene (MDR1, mdr1a and pgp1 respectively) as the
only isoform in the intestinal epithelium. Since Northern probing
unexpectedly revealed a greater expression of mdr1b than mdr1a
in IEC-18 cells, gene-specific RT-PCR assays were used to analyse
MDR transcripts in rat intestine and validate the use of IEC-18 as a
model.
The results confirm that the class I transcript is the predominant
MDR gene expressed in the adult intestine. However, lower levels
of both MDR class II and class III transcripts were also detected.
Although Furuya et al (1994) have reported the expression of class
III transcript in the rat intestine, detection of class II transcript in
the intestinal epithelium is a novel finding. Class II transcript has
not been detected in previous studies due to the use of techniques
with insufficient sensitivity, or because of experimental design
that implicity assumes only class I transcript is expressed in the
intestine.
The results presented here reveal that mdr1a transcript levels are
highest in the small intestine with lower levels in the colon. This is
consistent with the findings of Bremer et al (1992) and Trezise and
Buchwald (1991), who employed quantitative RT-PCR and RNA in
situ hybridization techniques respectively. Using isoform-specific
monoclonal antibodies in the hamster digestive tract, Bradley et al
(1990) identified the highest levels of pgp1 expression in the
caecum and proximal colon with barely detectable levels in the rest
of the intestine. The discrepancy with the Bradley findings are most
likely due to differences between transcript and protein expression.
At present, the regulation of mdr1a expression in normal tissue is
poorly understood, but is likely to occur at many levels including
gene amplification, transcription and translation.
Consistent with the findings of Tresize and Buchwald (1991),
variations in mdr1a level along the horizontal axis of the small
intestine were not large. However, expression across the
crypt–villus axis varied considerably, with villi expressing at least
an order of magnitude more than crypts or day 17 fetal intestine. In
contrast, mdr1b was expressed preferentially in small intestinal
crypts and fetal intestine, with levels in villi below the limits of
quantification. Thus, it appears that there is a conversion from
mixed mdr1a and mdr1b to predominantly mdr1a expression as
cells mature along the crypt–villus axis.
If the expression of MDR genes in fetal intestine reflects the
different function of the prenatal digestive tract, which is to absorb
amniotic fluid rather than digest food and excrete toxins, then
analysis of P-glycoprotein isoforms in the undifferentiated intes-
tine may shed light on their different physiologic functions. It is
likely that different functions of the MDR1 gene in humans are
divided between mdr1a and mdr1b in rodents. The observed
predominance of mdr1a in intestinal villi is consistent with a
protective function in the gut and this is borne out in mice with a
disrupted mdr1a gene (Borst and Schinkel, 1997). Mdr1a was
shown to be important for maintenance of the blood-brain barrier
and in the gut, unopposed reabsorption resulted in reduced clear-
ance of drugs dependent on P-glycoprotein transport.
Significantly, deletion of mdr1a expression resulted in an increase
in mdr1b transcript in liver and kidney, but expression in the
intestinal epithelium was not assessed.
The mdr1a and mdr1b expression pattern of IEC cells was
shown to be much more similar to fetal or small intestinal crypt
cells than villus cells. Fetal intestinal cells and adult crypts cells
are thought to be phenotypically similar (Quaroni, 1986), and cells
of the IEC series are thought to represent primitive, undifferenti-
ated intestinal epithelial cells based on their surface antigen profile
and their developmental potential (Quaroni et al, 1979; Quaroni
and Isselbacher, 1981; Quaroni, 1985). The findings of this study
lend further support to this concept. The pattern of MDR transcript
expression in IEC cells therefore, make them an appropriate model
for the analysis of MDR gene regulation in undifferentiated
intestinal epithelial cells.
Multidrug resistance genes in the intestinal epithelium 1129
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Figure 7 Enhancer sequence alignment. The sequence of the hamster pgp1 enhancer from –102 to –52 is depicted, aligned with the available MDR gene
promoters. There is significant conservation across the region, with the NF-IL6 binding site boxed and the 14 nucleotide stretch (Cohen et al, 1994) underlinedIn this report, MDR gene expression in IEC-18 cells was char-
acterized as a model system with which to explore transcriptional
regulation in the undifferentiated intestinal epithelium. Two
unique contributions to this field are described. One, the initial
identification of an undifferentiated cell-specific enhancer region
in the hamster mdr1a promoter and the other, detection of mdr1b
expression in primitive intestinal cell types. Intriguingly, the
enhancer was identified in the promoter of mdr1a, a transcript
which is more highly expressed in differentiated intestinal cells. It
remains to be determined whether this is due to relatively
increased activity of an mdr1a repressor, or decreased mdr1a tran-
script stability in undifferentiated cells. This work provides a basis
for such future studies and to discover new transcription factors
involved in determining cellular identity during intestinal develop-
ment, differentiation and tumorigenesis.
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